Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at low dose cyclophosphamide for bowel cancer (BICCC)

Overview

Cancer types:

Bowel (colorectal) cancer, Colon cancer, Rectal cancer

Status:

Open

Phase:

Phase 2

Details

This trial is looking at having cyclophosphamide chemotherapy. This is after completing treatment for bowel cancer.

It is for people who:

  • were diagnosed with cancer that had grown into the lining of the bowel wall but had spread no further than to one other in the body. This is stage 2, stage 3 or stage 4A bowel cancer.

  • had surgery with or without chemotherapy to treat their bowel cancer

Recruitment start: 18 July 2024

Recruitment end: 1 March 2027

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Andrew Godkin

Supported by

Cardiff University

Cancer Research Wales

Last reviewed: 26 Feb 2026

CRUK internal database number: 20113

Help and support